Not just data
Alongside clinical and biological inputs, it emphasizes treatment continuity, symptom visibility, and day-to-day care flow.
Onco Atlas
From fragmented data to structured context.
Turning the whisper of cells into decisions.
- Built around oncology workflow realities
- Designed for continuity of care
- Structured for pilot evaluation
- Patient-journey focused
Data Policy
Data is not stored. It is analyzed and automatically deleted at the end of the session.
Important Notice
Demo outputs must not be used for clinical diagnosis or treatment decisions.
FHIR v4.0 aligned (self-declared)
SaMD scope & regulatory readiness roadmap
Integration
- HL7 FHIR v4.0–oriented design for HIS interoperability
- Enterprise-grade data model and scalable backend
Regulatory preparation
- SaMD (Software as a Medical Device) scope assessment
- MDR / CE and FDA pathways: preparation & documentation (no approval claimed)
Global privacy & security alignment
- Designed for privacy-conscious clinical workflows
Zynova OncoAtlas is designed with privacy, security, and clinician-supervised workflows in mind. No regulatory clearance, certification, or autonomous clinical decision claim is made.
⚠️This report was developed by Zynova Sağlık Teknolojileri Ltd. Şti. and is intended solely for clinical decision support purposes. It does not constitute medical diagnosis or treatment recommendation. All clinical decisions and treatment implementations remain the sole responsibility of the licensed physician evaluating the patient. This content does not replace the physician-patient relationship under any circumstances.
Why Zynova?
Many oncology platforms focus on analyzing data. Zynova focuses on making the patient journey more visible, trackable, and manageable.
Not just for institutions
It supports institutional workflows while also addressing the less visible gaps between patients and care teams.
Not just analysis
It turns fragmented treatment steps and symptom signals into structured documentation and evidence navigation for clinical review support.
Zynova is built not only to understand cancer data, but to make the cancer journey easier to navigate.
The challenge in oncology case review
Oncology teams often receive pathology, PET/CT, molecular, laboratory, and epicrisis documents from different systems and timelines. Clinical context can fragment before tumor board or case review.
- Pathology, imaging, and molecular results live in separate reports
- Prior therapy and lab markers are easy to miss across documents
- Case-specific review slows when evidence is not aligned on one surface
What Zynova OncoAtlas Does
An AI-assisted oncology workflow intelligence and evidence navigation platform — structured around how oncology teams prepare cases, navigate evidence, and maintain continuity of care.
- Structures fragmented patient data into a structured oncology timeline
- Supports evidence navigation across guidelines, trials, and genomic context
- Streamlines tumor board preparation and care handoffs between teams
- Designed for clinical workflow support — not treatment automation or automated diagnosis
One case-specific clinical view
Zynova OncoAtlas structures a document set into a single case-specific workflow view — with separate patient and physician report surfaces that stay aligned on clinical truth.
- Evidence navigation across pathology, imaging, molecular, and lab inputs
- Report consistency and contradiction awareness for case-specific review
- Structured outputs for physician-led review — not automated diagnosis
A new cancer diagnosis appears every 2 minutes.
A physician has 15 minutes in hand.
The latest research was published 6 hours ago.
No one can read everything.
Zynova was built to close this gap.
4,495+
January 2026 publication scale; prioritized for case context
260
Source updates are processed to keep matching context current
Continuous
Open data is structured into traceable, rationale-backed clinical output
73%
Cross-country reimbursement variance
Key Capabilities
Structured Oncology Timeline
Consolidates imaging, pathology, labs, and notes into a structured oncology timeline that supports clinical reasoning across the care pathway.
🧬
3D Anatomical Context
Visualizes tumor location and spread for tumor board preparation and multidisciplinary discussion — designed for clinical workflow support.
Evidence Navigation for Trials
Filters trial sources by case context with traceable rationale — evidence navigation for physician-led review, not automated trial assignment.
Guideline & Protocol Context
Surfaces NCCN, ESMO, and ASCO reference context alongside formulary signals to support protocol discussion — not guaranteed treatment protocols.
Genomic Context Layer
Maps biomarker and genomic findings to anatomy-aware summaries that support interpretation; the physician remains the final decision-maker.
Tumor Board Preparation
Prepares structured case materials for tumor boards and remote multidisciplinary reviews without replacing physician judgment.
Clarity for institutional evaluation
Product choices reflect clinical process realities, continuity of care, and patient-journey needs — not hype.
Clinical relevance
Reflects familiar pressures in oncology practice: document load, protocol discussion, and multidisciplinary coordination.
Patient journey
A single-timeline mindset from diagnosis through follow-up — visibility and continuity as care transitions between teams.
Institutional readiness
Structured with scoped pilots and feedback loops in mind — focused on operational fit, not headline claims.
This section carries no diagnosis, approval, or reimbursement commitment — it summarizes how the product is positioned.
Document-grounded. Clinician-led. Safety-aware.
Clinical workflow intelligence grounded in uploaded documents — designed for evidence navigation and report consistency, with safety-aware guardrails.
- Document-grounded extraction and case-specific structuring
- Clinician-led review; outputs support — not replace — clinical reasoning
- Safety-aware report consistency across patient and physician surfaces
Zynova OncoAtlas does not replace physician judgment.
Human-in-the-Loop Clinical Support
Zynova supports clinical reasoning and evidence navigation. It does not diagnose, prescribe, or replace licensed physicians. Every output is prepared for physician review and tumor board discussion.
Supports clinical reasoning; does not decide or recommend treatment
Structured outputs for physician review — not instant medical decisions
Physician remains the final decision-maker at every step
Who it is for
Built for teams that need document-grounded oncology workflow intelligence — without replacing physician judgment.
Oncologists
Case-specific clinical review, evidence navigation, and tumor board preparation from a unified document set.
Hospitals
Structured multidisciplinary workflows, institutional pilot evaluation, and aligned patient/physician report surfaces.
Molecular pathology & diagnostic partners
Molecular findings connected to case context, report consistency, and workflow-ready summaries for clinical review.
For Oncology Teams, Hospitals & Tumor Boards
🏥
Hospitals & cancer centers
Accelerate tumor board preparation, multidisciplinary meetings, and case intake with structured workflow intelligence — the physician remains the final decision-maker.
👥
Tumor boards & MDT teams
Case packets, evidence summaries, and continuity notes for board-ready discussion — supports clinical reasoning without issuing treatment directives.
🩺
Oncology practices & networks
Unify documents and timelines on one surface for evidence navigation and follow-up continuity across sites and handoffs.
Enterprise Readiness
Built for institutional evaluation: pilot pathways, role-aware access conversations, and workflow alignment with hospital and cancer-center operating models.
- Structured pilot evaluation and feedback cycles with defined scope
- Session-based processing boundaries aligned to clinical workflow support
- Deployment discussions scaled to team structure, tumor board cadence, and IT context
About Zynova
Zynova Global - OncoAtlas is a health technology company shaped by real oncology needs. Our focus is to make the patient journey more visible, trackable, and manageable.
Founder Perspective
Founded by Gokhan Dincaslan, with over 23 years across the oncology ecosystem, Zynova combines pharma and operational field experience with an innovation-focused product vision.
Explore content and workflow depth
Review concise, structured surfaces that explain not only what Zynova offers, but how it fits oncology workflow in practice.
Use Cases
Product application pages for case intake, trial matching, and report output workflows.
Insights
Short, problem-oriented pieces on oncology operations and clinical review preparation.
Knowledge Base
Foundational terms such as ECOG, biomarker context, and trial eligibility.
Clinical AI
Perspective on supporting workflow with AI without replacing physician judgment.
Explore the workflow before you commit.
No login required for first exploration. Designed for clinical workflow support — demo outputs are not for diagnosis.
After a short product tour, the demo lets teams evaluate workflow and patient-journey scenarios in a structured, low-risk way.
Zynova’s value is workflow intelligence and evidence navigation — structuring fragmented oncology data around tumor type, biomarker, stage, and clinical context so teams can prepare tumor boards and continuity handoffs more clearly.
The goal is not more records on screen, but clearer workflow support for physician-led review — the physician remains the final decision-maker.
400,000+
Broad trial coverage; case-aware prioritization over raw listing
Source: ClinicalTrials.gov + WHO ICTRP
1,000+
Genomic layer connected to report-ready interpretation flow
47
Cancer-type coverage presented in a structured clinician-facing format
Based on WHO ICD-O-3 major groups
23
Countries
~1 min
Sample turnaround for physician-readable report preview
Coverage
A broad data layer monitors information across relevant clinical sources and brings it into a single working surface.
Relevance
Data is prioritized according to case context, biomarker signals, stage, and clinical fit.
Usability
The result is a shortlist, rationale, and report-ready layer that physicians can review more efficiently.
Evidence & Validation Roadmap
Zynova OncoAtlas is in active R&D and beta evaluation. Rather than claiming clinical performance, it aims to transparently track pilot metrics such as data extraction, missing critical data detection, trial-shortlist relevance, and physician review time.
Report extraction
Missing critical data
Trial shortlisting
Physician review time
Beta Metrics
Beta Phase
Active development
47+
Cancer-type coverage structured for clinical context
400k+
Trial coverage filtered by case relevance, not raw listing
1000+
Genomic layer linked to interpretable report flow
Zynova OncoAtlas is in active R&D phase. Figures are periodically updated.
Start with a controlled institutional pilot
Evaluate Zynova in your institution with a defined scope — focused on clinical workflow review, not performance claims.
- 30–60 day structured evaluation window
- Limited user group with role-appropriate access
- Structured feedback cycles with your clinical workflow team
- Sample, synthetic, or institution-approved cases only
- Clinical workflow review — evidence navigation and report consistency
Evaluate Zynova for your oncology workflow
Request an institutional pilot, book a clinical workflow demo, or explore a sample case — structured for physician-led review.
Zynova OncoAtlas Pro
Professional oncology workflow, evidence navigation, and reporting platform. Supports — does not replace — licensed physician judgment.
$49 monthly
$490 yearly
2 months free with annual billing
- •1 physician account
- •Up to 40 cases per month
- •Private pilot
Purchasing will open soon
Request pilot accessFor corporate communication and partnership inquiries, please visit our Contact page.
Zynova OncoAtlas supports oncology workflow, evidence navigation, and clinical documentation. It does not diagnose, prescribe treatment, or replace licensed physicians.